Literature DB >> 15247324

A novel 4-base-recognizing RNA cutter that can remove the single 3' terminal nucleotides from RNA molecules.

Hiroaki Takaku1, Asako Minagawa, Masamichi Takagi, Masayuki Nashimoto.   

Abstract

Mammalian tRNase ZL shows versatility in substrate recognition. This enzyme can not only process pre-tRNAs by cleaving off their 3' trailer sequences, but also recognize and cleave pre-tRNA-like complexes and micro-pre-tRNAs. Here we demonstrate that 24-27 nt hairpin RNAs (hook RNAs) can guide cleavages of separate target RNAs by tRNase ZL through the micro-pre-tRNA-like complexes between the targets and the hook RNAs and that tRNase ZL together with hook RNA works as 4-7-base-recognizing RNA cutters. The cleavage sites were located only after the nucleotide corresponding to the discriminator nucleotide. Cleavage assays for various substrate/hooker complexes showed that the cleavage efficiency changes depending on the maximum number of substrate/hooker recognition base pairings and the stem length of hook RNA and that a 5 nt recognition sequence and a hook RNA containing a 6 or 7 bp stem are the best combination for the optimal target cleavage. We also show that a 4-base RNA cutter can remove the single 3' terminal nucleotides from RNA molecules. These results indicate that this new type of RNA cutter can be utilized to homogenize at their 3' termini RNA transcripts synthesized in vitro with a bacteriophage RNA polymerase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15247324      PMCID: PMC443559          DOI: 10.1093/nar/gnh092

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  23 in total

1.  A universal method to produce in vitro transcripts with homogeneous 3' ends.

Authors:  Heike Schürer; Kathrin Lang; Jens Schuster; Mario Mörl
Journal:  Nucleic Acids Res       Date:  2002-06-15       Impact factor: 16.971

2.  Intracellular mRNA cleavage by 3' tRNase under the direction of 2'-O-methyl RNA heptamers.

Authors:  Masato Tamura; Chikako Nashimoto; Noriko Miyake; Yasushi Daikuhara; Kozo Ochi; Masayuki Nashimoto
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

3.  General plasmids for producing RNA in vitro transcripts with homogeneous ends.

Authors:  Scott C Walker; Johanna M Avis; Graeme L Conn
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

4.  Generating in vitro transcripts with homogenous 3' ends using trans-acting antigenomic delta ribozyme.

Authors:  Agnieszka Wichlacz; Michał Legiewicz; Jerzy Ciesiołka
Journal:  Nucleic Acids Res       Date:  2004-02-18       Impact factor: 16.971

5.  Minimum requirements for substrates of mammalian tRNA 3' processing endoribonuclease.

Authors:  M Nashimoto; M Tamura; R L Kaspar
Journal:  Biochemistry       Date:  1999-09-14       Impact factor: 3.162

6.  Assigning a function to a conserved group of proteins: the tRNA 3'-processing enzymes.

Authors:  Steffen Schiffer; Sylvia Rösch; Anita Marchfelder
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

7.  Anomalous RNA substrates for mammalian tRNA 3' processing endoribonuclease.

Authors:  M Nashimoto
Journal:  FEBS Lett       Date:  2000-04-28       Impact factor: 4.124

8.  The inhibitory effect of the autoantigen La on in vitro 3' processing of mammalian precursor tRNAs.

Authors:  M Nashimoto; C Nashimoto; M Tamura; R L Kaspar; K Ochi
Journal:  J Mol Biol       Date:  2001-10-05       Impact factor: 5.469

9.  A candidate prostate cancer susceptibility gene encodes tRNA 3' processing endoribonuclease.

Authors:  Hiroaki Takaku; Asako Minagawa; Masamichi Takagi; Masayuki Nashimoto
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

10.  Drosophila RNase Z processes mitochondrial and nuclear pre-tRNA 3' ends in vivo.

Authors:  Edward B Dubrovsky; Veronica A Dubrovskaya; Louis Levinger; Steffen Schiffer; Anita Marchfelder
Journal:  Nucleic Acids Res       Date:  2004-01-09       Impact factor: 16.971

View more
  14 in total

Review 1.  TRUE Gene Silencing.

Authors:  Masayuki Nashimoto
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

2.  TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents.

Authors:  Arisa Haino; Tatsuya Ishikawa; Mineaki Seki; Masayuki Nashimoto
Journal:  J Vis Exp       Date:  2016-06-02       Impact factor: 1.355

3.  Elimination of specific miRNAs by naked 14-nt sgRNAs.

Authors:  Masayuki Takahashi; Reyad A Elbarbary; Mayumi Abe; Mari Sato; Tetsuo Yoshida; Yoji Yamada; Masato Tamura; Masayuki Nashimoto
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

4.  Inhibition of HIV-1 gene expression by retroviral vector-mediated small-guide RNAs that direct specific RNA cleavage by tRNase ZL.

Authors:  Yuichiro Habu; Naoko Miyano-Kurosaki; Michiko Kitano; Yumihiko Endo; Masakazu Yukita; Shigeru Ohira; Hiroaki Takaku; Masayuki Nashimoto; Hiroshi Takaku
Journal:  Nucleic Acids Res       Date:  2005-01-12       Impact factor: 16.971

5.  Growth inhibition of head and neck squamous cell carcinoma cells by sgRNA targeting the cyclin D1 mRNA based on TRUE gene silencing.

Authors:  Satoshi Iizuka; Nobuhiko Oridate; Masayuki Nashimoto; Satoshi Fukuda; Masato Tamura
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

6.  Potential small guide RNAs for tRNase ZL from human plasma, peripheral blood mononuclear cells, and cultured cell lines.

Authors:  Sho Ninomiya; Mitsuoki Kawano; Takashi Abe; Tatsuya Ishikawa; Masayuki Takahashi; Masato Tamura; Yoshiaki Takahashi; Masayuki Nashimoto
Journal:  PLoS One       Date:  2015-03-02       Impact factor: 3.240

7.  SIDT2 mediates gymnosis, the uptake of naked single-stranded oligonucleotides into living cells.

Authors:  Masayuki Takahashi; Viorica Raluca Contu; Chihana Kabuta; Katsunori Hase; Yuuki Fujiwara; Keiji Wada; Tomohiro Kabuta
Journal:  RNA Biol       Date:  2017-04-17       Impact factor: 4.652

8.  Modulation of gene expression by human cytosolic tRNase Z(L) through 5'-half-tRNA.

Authors:  Reyad A Elbarbary; Hiroaki Takaku; Naoto Uchiumi; Hiroko Tamiya; Mayumi Abe; Masayuki Takahashi; Hiroshi Nishida; Masayuki Nashimoto
Journal:  PLoS One       Date:  2009-06-15       Impact factor: 3.240

9.  Optimization and characterization of tRNA-shRNA expression constructs.

Authors:  Lisa J Scherer; Richard Frank; John J Rossi
Journal:  Nucleic Acids Res       Date:  2007-04-10       Impact factor: 16.971

Review 10.  The dysregulation of tRNAs and tRNA derivatives in cancer.

Authors:  Shi-Qiong Huang; Bao Sun; Zong-Ping Xiong; Yan Shu; Hong-Hao Zhou; Wei Zhang; Jing Xiong; Qing Li
Journal:  J Exp Clin Cancer Res       Date:  2018-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.